Intermountain, Asia Genomics partner for personalized medicine
13-Sep-16, Healthcare IT News
Intermountain Precision Genomics and Asia Genomics are joining forces to deliver personalized medicine. First up is a test in Southeast Asia.
%20Healthcare%20IT%20News.png "Intermountain Asia Genomics partner for personalized medicine (c) Healthcare IT News")
Image: Healthcare IT News
Under the collaboration deal, the first for Intermountain Precision Genomics outside of the US, Asia Genomics is contracting with Intermountain Precision Genomics to offer ICG100 testing.
The ICG100 test is next generation sequencing that identifies mutations within a person’s cancer to identify specific DNA targets for personalized drug treatments. The IGC100 test is approved for late stage cancer patients who have failed a traditional treatment method, offering new hope when traditional treatments don’t work.
Asia Genomics has been offering various types of genomic tests in the healthcare environment since 2014. The tests primarily center on reproductive health and cancer care.